Clinical Evaluation of the Photoallergy Potential of Atralin Gel

Coria Laboratories, Ltd.40 enrolled

Overview

To assess the potential of tretinoin gel 0.05% and its vehicle to produce photoallergic reactions, measured as skin reactions following induction and challenge.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

SINGLE

Enrollment

Conditions

Healthy

Interventions

Atralin (tretinoin) gel, 0.05%DRUG

Assess photoallergic reactions for tretinoin 0.05% and vehicle, measured as skin reactions following induction and challenge.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Normal, healthy volunteers * 18 years of age and older Exclusion Criteria: * Less than 18 years of age

Locations (1)

Suncare Research Laboratories

Winston-Salem, North Carolina, United States

Outcomes

Primary Outcomes

UV Induced skin irritation

Time frame: 4 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.